Xenoview (Xenon Xe 129 hyperpolarized)
Drug Name: Xenoview
API: Xenon Xe 129 hyperpolarized
Dosage Forms and Strengths:
Xenoview is a clear, colorless, odorless gas contained in a 1,000 mL Xenoview Dose Delivery Bag.
- The strength is DE per 1,000 mL administered.
- Manufactured by: Polarean, Inc.
- The recommended target dose of XENOVIEW for adult and pediatric patients aged 12 years and older is 75 mL to 100 mL Dose Equivalent (DE) of hyperpolarized xenon Xe 129 by oral inhalation of the entire contents of one XENOVIEW Dose Delivery Bag.
- Each bag contains at least 75 mL DE of hyperpolarized xenon Xe 129 with a recommended target DE range of 75 mL to 100 mL measured within 5 minutes of administration, in a volume of 250 mL to 750 mL total xenon with additional nitrogen, NF (99.999% purity) added to reach a total volume of 1,000 mL.
- Administer the dose within 5 minutes of DE measurement.
- Initiate imaging immediately after inhalation.
- Refer to the Full Prescribing Information for detailed information regarding preparation, administration, image acquisition, and image interpretation.
- Risk of Decreased Image Quality from Supplemental Oxygen: The administration of supplemental oxygen simultaneously with XENOVIEW inhalation can cause degradation of image quality. For patients on supplemental oxygen, withhold oxygen inhalation for two breaths prior to XENOVIEW inhalation, and resume oxygen inhalation immediately following the imaging breath hold.
- Risk of Transient Hypoxia: Inhalation of an anoxic gas such as XENOVIEW may cause transient hypoxemia in susceptible patients. Monitor all patients for oxygen saturation and symptoms of hypoxemia, and treat as clinically indicated.
If you are considering the import of Xenon Xe 129 hyperpolarized to India, please be aware that Xenoview can be imported by patients or government hospitals solely in the name of the patients. The following documentation is essential for the successful import of this medication:
Required Documentation for Import:
- A valid prescription from a qualified medical practitioner.
- Diagnostic reports of the patient.
- Government-issued identification proof for the patient, as recognized by the Government of India.
Order Confirmation Process:
The order for Xenoview will be confirmed upon the receipt of the following documents:
- A valid prescription from a qualified doctor.
- An import permit, if applicable.
Availability of Xenoview in India:
Xenon Xe 129 hyperpolarized is classified as a prescription pharmaceutical drug. Consequently, it legally requires a medical prescription to be dispensed. Indian Pharma Network (IPN) specializes in facilitating the import of cancer medicines through named patient supply (NPS), ensuring transparency and authenticity by sourcing from reputable suppliers in the USA, Canada, Europe, and Australia.
Xenon Xe 129 hyperpolarized can be made accessible to patients, doctors, and hospitals in various cities across India, including but not limited to Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune. To confirm an order, a valid prescription from a doctor and an import permit will be required.
IPN (Indian Pharma Network) is dedicated to facilitating the supply of Xenoview (prescription medicines) to locations both within India and worldwide, while adhering to relevant legal requirements.
Indian Pharma Network is proficient in sourcing Xenon Xe 129 hyperpolarized from around the world and ensuring efficient delivery to patients. We provide worldwide access to the best available treatments and expedite prescription dispensing and delivery, with all prescriptions being dispensed and scrutinized by registered pharmacists before dispatching them to the patient’s address, exclusively from New Delhi, India.
Is xenon 129 FDA approved?
The US FDA has granted Polarean Imaging plc approval for its drug device combination product, XENOVIEW. XENOVIEW, prepared from the Xenon Xe 129 Gas Blend, is a hyperpolarized contrast agent indicated for use with MR imaging for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older.
Who manufactures Xenoview?
With dosing performed via one 10- to 15-second breath hold MRI procedure, Xenoview (xenon Xe 129 hyperpolarized) offers enhanced visualization of lung ventilation to aid clinicians in the management of lung disease without the need for ionizing radiation, according to Polarean Imaging, the manufacturer of Xenoview.
What is the indication of xenoview?
XENOVIEW, prepared from the Xenon Xe 129 Gas Blend, is indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older.
What is the mechanism of action of xenoview?
The unique mechanism of action of hyperpolarized Xe 129 MRI mechanistically lies in the gas preparation itself. It is through the hyperpolarization creating a quantitively distinct volume DE specific for the patient’s anatomy that begins the novel imaging using MRI.
Is Xenoview FDA approved?
Yes, Xenoview gotn approved by FDA in 2022.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.